American Academy of Pediatrics Issues Annual Influenza Season Recommendations

September 19, 2020

The American Academy of Pediatrics (AAP) has issued its recommendations for the 2020-2021 influenza season.

FDA OKs Hybrid Closed Loop Diabetes Management Device for Use in Young Children

September 01, 2020

The MiniMed 770G system (Medtronic) is approved for use by individuals aged 2 to 6 with type 1 diabetes.

NACDS Urges Further State Action to Affirm Pharmacist-Administered Childhood Vaccinations

August 27, 2020

NACDS is urging states to provide clarity on pharmacist-provided childhood vaccinations, and enhance overall patient access to vaccines.

Pharmacy Groups Voice Support for Pharmacist-Provided Childhood Vaccines After AAP Opposition

August 24, 2020

Twelve pharmacy organization issued a joint statement in response to the expansion of the pharmacist's role in providing vaccines to children.

Pandemic Presents Unique Challenges for ADHD Management

August 20, 2020

Caregivers of children with ADHD can choose from an increasing number of treatments that can be customized.

FDA OKs New Treatment for Seizures Associated with Dravet Syndrome

June 26, 2020

Officials with the FDA approved fenfluramine (Fintepla, Zogenix) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.

Children’s Cough Relief Products Recalled for Wrong Dosing Cups

June 23, 2020

The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.

Gilead Announces Plans for Pediatric COVID-19 Trial of Remdesivir

June 18, 2020

The phase 2/3 trials will evaluate remdesivir (Gilead) in pediatric patients, from newborns to adolescents, who have contracted severe COVID-19 symptoms.

FDA Clears First Prescription Game-Based Treatment Device for Children With ADHD

June 17, 2020

EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.

Projected US Pediatric COVID-19 Numbers Could Overextend Resources

May 04, 2020

The study warned that, with 74 million children in the United States, PICU resources could face concerning strain from COVID-19.